Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms

Fig. 5

MGMT status in GI-NETs and GI-NECs. 5-1 H-scores were not significantly different between NETs and NECs. Data are expressed as mean ± SD (round the fourth digit). 5-2 MGMT promoter hypermethylation was detected in two (case 38, 48) of 14 GI-NEC patients. 5-3 Representative images of MGMT immunohistochemistry of case 38 and 48. Case 38 and 48 demonstrated MGMT score 0 and score 3, respectively

Back to article page